Yearly Archives: 2015
Blockbuster Launch Evolution: Learning to See the Market in Different Wavelengths and Perspectives (Part 2)
One of the areas within the Pharmaceutical and related industries which has the main goal of seeing market opportunities is the Market Research function. Despite this, many organizations’ Market Research groups do not have 20/20 vision. Much like many animals
New Series: Blockbuster Pharmaceutical Drugs Launch Evolution (Part-1)
Take a look at the slide below and see if you can answer which of the 5 drugs had a peak sales year of $13.7 billion. The answer? – Lipitor While Lipitor sold a gigantic $13.7 billion in their peak sales year,
Hotspots in Biopharma Digital Marketing Innovation
The rapid growth of digital, mobile and related technologies has transformed the global communications paradigm, and with it, changed the ways in which consumers and professionals access information. In case of the biopharmaceutical and medical device industry, the development of
Adopting the New Patient Journey Framework for Marketing
Marketing within the healthcare industry has been rapidly changing due to the growing influence of patients. Physicians are no longer the main focus in marketing when trying to determine market access and product launch success. Because patients are becoming more
Can Sovaldi’s Launch Success Be Repeated? Examining How Gilead Sciences Utilized Marketing Mix To Rewrite Launch History
We all know this story: Ninety-five percent of drugs in the development pipeline fail to clear the safety and efficacy profiles, and companies then add that R&D cost of such failures to the price of the drug that does reach the
Creating and Maintaining a Strategic KOL Management and Engagement System
Across the pharmaceutical sector, regulatory and access issues have reshaped interactions with Key Opinion Leaders (KOLs). And with KOL interactions affecting everything from clinical development to product launch, the issue of strategically managing these critical exchanges looms large for small
Role of Medical Affairs Increasing in Oncology Launch
The Medical Affairs function plays a vital role in a host of oncology activities, including identification and engagement of Key Thought Leaders to guidance of commercial strategies and launch resources management. It is becoming increasingly apparent that a successful launch
Frustrations of a Pharmaceutical Market Researcher…
Not that long ago, I was updating a key research project here at Best Practices; and as usual, I was waiting on approval from our research manager. The approval delay made me agitated, but not nearly as much as when
Best Practices Hosts 7th Digital Marketing Consortium Roundtable
Best Practices hosted our 7th Digital Marketing Consortium Roundtable on Thursday, July 23. The topic of the virtual conference was “Key Trends & Innovative Activities in 2015 Biopharma Digital Marketing.” The roundtable brought together executives from 8 leading pharmaceutical companies
Best Practices Hosting 6th Medical Affairs Consortium on HEOR
Best Practices will be hosting the sixth roundtable of our Medical Affairs Consortium on Thursday (May 28th) from 11:00AM-12:30PM (EST) via a virtual roundtable to discuss “Medical Affairs’ Role in Health Economics & Outcomes Research.” This is the final roundtable
As Mobile Surpasses Desktop Search, Poll of Digital Marketers Finds Industry Divided on Pharma’s Next Steps
In a digital advertising conference yesterday, Google announced that mobile searches have surpassed desktop searches in the U.S. and numerous other countries. This is big news, but a not necessarily stunning development to anyone paying close attention to the inexorable